LLL

LUYE PHARMA GROUP LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.31 B‬EUR
‪68.27 M‬EUR
‪787.39 M‬EUR
‪1.85 B‬
Beta (1Y)
0.94

About LUYE PHARMA GROUP LIMITED

CEO
Dian Bo Liu
Headquarters
Yantai
Website
Employees (FY)
‪5.27 K‬
Founded
1994
Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LUP is 0.34 EUR — it has increased by 1.18% in the past 24 hours. Watch LUYE PHARMA GROUP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange LUYE PHARMA GROUP LTD stocks are traded under the ticker LUP.
LUYE PHARMA GROUP LTD is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
LUP stock is 1.17% volatile and has beta coefficient of 0.94. Track LUYE PHARMA GROUP LTD stock price on the chart and check out the list of the most volatile stocks — is LUYE PHARMA GROUP LTD there?
Yes, you can track LUYE PHARMA GROUP LTD financials in yearly and quarterly reports right on TradingView.
LUP stock has risen by 1.18% compared to the previous week, the month change is a 5.52% rise, over the last year LUYE PHARMA GROUP LTD has showed a 20.37% decrease.
LUP net income for the last quarter is ‪47.95 M‬ EUR, while the quarter before that showed ‪19.84 M‬ EUR of net income which accounts for 141.70% change. Track more LUYE PHARMA GROUP LTD financial stats to get the full picture.
Today LUYE PHARMA GROUP LTD has the market capitalization of ‪1.33 B‬, it has increased by 9.62% over the last week.
LUYE PHARMA GROUP LTD dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, LUP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUYE PHARMA GROUP LTD stock right from TradingView charts — choose your broker and connect to your account.
LUP reached its all-time high on Apr 13, 2015 with the price of 1.39 EUR, and its all-time low was 0.25 EUR and was reached on Oct 31, 2022. View more price dynamics on LUP chart.
See other stocks reaching their highest and lowest prices.
As of May 10, 2024, the company has ‪5.27 K‬ employees. See our rating of the largest employees — is LUYE PHARMA GROUP LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LUYE PHARMA GROUP LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LUYE PHARMA GROUP LTD stock shows the sell signal. See more of LUYE PHARMA GROUP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LUYE PHARMA GROUP LTD future price: according to them, LUP price has a max estimate of 0.59 EUR and a min estimate of 0.29 EUR. Watch LUP chart and read a more detailed LUYE PHARMA GROUP LTD stock forecast: see what analysts think of LUYE PHARMA GROUP LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LUYE PHARMA GROUP LTD EBITDA is ‪206.31 M‬ EUR, and current EBITDA margin is 26.37%. See more stats in LUYE PHARMA GROUP LTD financial statements.